These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29193204)

  • 1. Engineered agrin attenuates the severity of experimental autoimmune myasthenia gravis.
    Li Z; Li M; Wood K; Hettwer S; Muley SA; Shi FD; Liu Q; Ladha SS
    Muscle Nerve; 2018 May; 57(5):814-820. PubMed ID: 29193204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MuSK induced experimental autoimmune myasthenia gravis does not require IgG1 antibody to MuSK.
    Küçükerden M; Huda R; Tüzün E; Yılmaz A; Skriapa L; Trakas N; Strait RT; Finkelman FD; Kabadayı S; Zisimopoulou P; Tzartos S; Christadoss P
    J Neuroimmunol; 2016 Jun; 295-296():84-92. PubMed ID: 27235354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
    Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
    Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.
    Oshima M; Iida-Klein A; Maruta T; Deitiker PR; Atassi MZ
    Autoimmunity; 2017 Sep; 50(6):346-353. PubMed ID: 28850269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
    Losen M; Stassen MH; Martínez-Martínez P; Machiels BM; Duimel H; Frederik P; Veldman H; Wokke JH; Spaans F; Vincent A; De Baets MH
    Brain; 2005 Oct; 128(Pt 10):2327-37. PubMed ID: 16150851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injection of inactive Bordetella pertussis and complete Freund's adjuvant with Torpedo californica AChR increases the occurrence of experimental autoimmune myasthenia gravis in C57BL/6 mice.
    Maruta T; Oshima M; Mosier DR; Atassi MZ
    Autoimmunity; 2017 Aug; 50(5):293-305. PubMed ID: 28548588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental autoimmune model of muscle-specific kinase specific myasthenia gravis in rats].
    Chen Y; Wang HB; Wang YJ
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(17):1292-6. PubMed ID: 24029475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous IL-9 Ameliorates Experimental Autoimmune Myasthenia Gravis Symptoms in Rats.
    Yao X; Zhao J; Kong Q; Xie X; Wang J; Sun B; Xu L; Mu L; Li H
    Immunol Invest; 2018 Oct; 47(7):712-724. PubMed ID: 29944018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression of experimental autoimmune myasthenia gravis by mycophenolate mofetil.
    Janssen SP; Phernambucq M; Martinez-Martinez P; De Baets MH; Losen M
    J Neuroimmunol; 2008 Sep; 201-202():111-20. PubMed ID: 18667242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Anti-agrin Antibodies Causes Myasthenia Gravis in Mice.
    Yan M; Liu Z; Fei E; Chen W; Lai X; Luo B; Chen P; Jing H; Pan JX; Rivner MH; Xiong WC; Mei L
    Neuroscience; 2018 Mar; 373():113-121. PubMed ID: 29339325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis.
    Martínez-Martínez P; Losen M; Duimel H; Frederik P; Spaans F; Molenaar P; Vincent A; De Baets MH
    Am J Pathol; 2007 Feb; 170(2):644-57. PubMed ID: 17255332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells.
    Wang W; Milani M; Ostlie N; Okita D; Agarwal RK; Caspi RR; Conti-Fine BM
    J Immunol; 2007 Jun; 178(11):7072-80. PubMed ID: 17513756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific immunotherapeutic vaccine for experimental autoimmune myasthenia gravis.
    Luo J; Lindstrom J
    J Immunol; 2014 Nov; 193(10):5044-55. PubMed ID: 25288571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholine receptor-specific immunosuppressive therapy of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Luo J; Lindstrom J
    Ann N Y Acad Sci; 2018 Feb; 1413(1):76-81. PubMed ID: 29377167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes.
    Richman DP; Nishi K; Morell SW; Chang JM; Ferns MJ; Wollmann RL; Maselli RA; Schnier J; Agius MA
    Arch Neurol; 2012 Apr; 69(4):453-60. PubMed ID: 22158720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of myasthenia by immunization against muscle-specific kinase.
    Shigemoto K; Kubo S; Maruyama N; Hato N; Yamada H; Jie C; Kobayashi N; Mominoki K; Abe Y; Ueda N; Matsuda S
    J Clin Invest; 2006 Apr; 116(4):1016-24. PubMed ID: 16557298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis experimentally induced with muscle-specific kinase.
    Shigemoto K; Kubo S; Jie C; Hato N; Abe Y; Ueda N; Kobayashi N; Kameda K; Mominoki K; Miyazawa A; Ishigami A; Matsuda S; Maruyama N
    Ann N Y Acad Sci; 2008; 1132():93-8. PubMed ID: 18096854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Teriflunomide on B Cell Subsets in MuSK-Induced Experimental Autoimmune Myasthenia Gravis and Multiple Sclerosis.
    Yilmaz V; Ulusoy C; Hajtovic S; Turkoglu R; Kurtuncu M; Tzartos J; Lazaridis K; Tuzun E
    Immunol Invest; 2021 Aug; 50(6):671-684. PubMed ID: 32597289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel complement inhibitor limits severity of experimentally myasthenia gravis.
    Soltys J; Kusner LL; Young A; Richmonds C; Hatala D; Gong B; Shanmugavel V; Kaminski HJ
    Ann Neurol; 2009 Jan; 65(1):67-75. PubMed ID: 19194881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of passively transferred experimental autoimmune myasthenia gravis using papain.
    Poulas K; Tsouloufis T; Tzartos SJ
    Clin Exp Immunol; 2000 May; 120(2):363-8. PubMed ID: 10792389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.